National Bank Of Canada Sangamo Therapeutics, Inc Transaction History
National Bank Of Canada
- $81.9 Billion
- Q1 2025
A detailed history of National Bank Of Canada transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, National Bank Of Canada holds 2,281 shares of SGMO stock, worth $1,072. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,281
Previous 2,701
15.55%
Holding current value
$1,072
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SGMO
# of Institutions
136Shares Held
51MCall Options Held
2.17MPut Options Held
1.82M-
Vanguard Group Inc Valley Forge, PA9.37MShares$4.41 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT6.87MShares$3.23 Million0.03% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$2.21 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.17MShares$1.49 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.28MShares$1.07 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $73.6M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...